Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
Роль GSK-3 и микроРНК в эпителиально-мезенхимальном переходе и раковых стволовых клетках
2016-12-16
SCID: 54.1/2kgkgx3h
Discuss with AI
GSK-3Wnt/β-catenin signalingcancer stem cellsepithelial-mesenchymal transitionmicroRNAs
Figures from the paper
Abstract (AI)
// James A. McCubrey 1 , Timothy L. Fitzgerald 2 , Li V. Yang 3 , Kvin Lertpiriyapong 4 , Linda S. Steelman 1 , Stephen L. Abrams 1 , Giuseppe Montalto 5,6 , Melchiorre Cervello 6 , Luca M. Neri 7 , Lucio Cocco 8 , Alberto M. Martelli 8 , Piotr Laidler 9 , Joanna Dulińska-Litewka 9 , Dariusz Rakus 10 , Agnieszka Gizak 10 , Ferdinando Nicoletti 11 , Luca Falzone 11 , Saverio Candido 11 and Massimo Libra 11 1 Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC, USA 2 Department of Surgery, Brody School of Medicine at East Carolina University, Greenville, NC, USA 3 Department of Internal Medicine, Hematology/Oncology Section, Brody School of Medicine at East Carolina University, Greenville, NC, USA 4 Department of Comparative Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, USA 5 Biomedical Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy 6 Consiglio Nazionale delle Ricerche, Istituto di Biomedicina e Immunologia Molecolare “Alberto Monroy”, Palermo, Italy 7 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy 8 Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy 9 Chair of Medical Biochemistry, Jagiellonian University Medical College, Kraków, Poland 10 Department of Animal Molecular Physiology, Institute of Experimental Biology, Wroclaw University, Wroclaw, Poland 11 Department of Biomedical and Biotechnological Sciences – Oncological, Clinical and General Pathology Section, University of Catania, Catania, Italy Correspondence to: James A. McCubrey, email: // Massimo Libra, email: // Keywords : GSK-3, cancer stem cells, Wnt/beta-catenin, PI3K, Akt Received : October 28, 2016 Accepted : December 13, 2016 Published : December 16, 2016 Abstract Various signaling pathways exert critical roles in the epithelial to mesenchymal transition (EMT) and cancer stem cells (CSCs). The Wnt/beta-catenin, PI3K/PTEN/Akt/mTORC, Ras/Raf/MEK/ERK, hedgehog (Hh), Notch and TP53 pathways elicit essential regulatory influences on cancer initiation, EMT and progression. A common kinase involved in all these pathways is moon-lighting kinase glycogen synthase kinase-3 (GSK-3). These pathways are also regulated by micro-RNAs (miRs). TP53 and components of these pathways can regulate the expression of miRs. Targeting members of these pathways may improve cancer therapy in those malignancies that display their abnormal regulation. This review will discuss the interactions of the multi-functional GSK-3 enzyme in the Wnt/beta-catenin, PI3K/PTEN/Akt/mTORC, Ras/Raf/MEK/ERK, Hh, Notch and TP53 pathways. The regulation of these pathways by miRs and their effects on CSC generation, EMT, invasion and metastasis will be discussed.
Key Findings
1
GSK-3-related signaling is considered in the context of Wnt/β-catenin and PI3K/Akt pathways that influence EMT and cancer stem cells.
2
The abstract identifies GSK-3 and microRNAs as important regulators of epithelial–mesenchymal transition and cancer stem-cell biology.
3
The abstract is truncated and does not provide specific experimental results, quantitative comparisons, or stated limitations.
4
The paper examines interactions among signaling pathways and microRNA regulation as mechanisms affecting cancer progression.
Research Object
GSK-3 and microRNA-regulated epithelial–mesenchymal transition and cancer stem cells
Research Subject
The roles and signaling mechanisms of GSK-3 and microRNAs in regulating EMT and cancer stem-cell properties
Publication Details
Publication Date
2016-12-16
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest